Is palmoplantar pustulosis simply a variant of psoriasis or a distinct entity?

Journal of the European Academy of Dermatology and Venereology

Volumn 31, Issue 7, 2017, Pages e342-e343

  Misiak Galazka, M ^a   Wolska, H ^a   Rudnicka, L ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

USTEKINUMAB;

DRUG EFFICACY; GENE EXPRESSION; HUMAN; LETTER; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS; BULLOUS SKIN DISEASE; PSORIASIS; SYNDROME;

HUMANS; PSORIASIS; SKIN DISEASES, VESICULOBULLOUS; SYNDROME;

EID: 85024890287     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.14136     Document Type: Letter

References (10)

1. Misiak-Galazka M, Wolska H, Rudnicka L. What do we know about palmoplantar pustulosis? J Eur Acad Dermatol Venereol 2016; 13: 13846.
2. Brunasso AM, Puntoni M, Aberer W, Delfino C, Fancelli L, Massone C. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study. Br J Dermatol 2013; 168: 1243–1251.
3. Brunasso AM, Massone C. Can we really separate palmoplantar pustulosis from psoriasis? J Eur Acad Dermatol Venereol 2010; 24: 619–621; author reply 621.
4. Thomsen K, Osterbye P. Pustulosis palmaris et plantaris. Br J Dermatol 1973; 89: 293–296.
5. Bissonnette R, Suarez-Farinas M, Li X et al. Based on molecular profiling of gene expression, palmoplantar pustulosis and palmoplantar pustular psoriasis are highly related diseases that appear to be distinct from psoriasis vulgaris. PLoS ONE 2016; 11: e0155215.
6. Asumalahti K, Ameen M, Suomela S et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol 2003; 120: 627–632.
7. Mossner R, Kingo K, Kleensang A et al. Association of TNF -238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. J Invest Dermatol 2005; 124: 282–284.
8. Buder V, Herberger K, Jacobi A, Augustin M, Radtke MA. Ustekinumab in the treatment of palmoplantar pustular psoriasis - a case series of nine patients. J Dtsch Dermatol Ges 2016; 14: 1108–1113.
9. Bissonnette R, Nigen S, Langley RG et al. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial. J Eur Acad Dermatol Venereol 2014; 28: 1298–1305.
10. Kimball AB, Papp KA, Wasfi Y et al. Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study. J Eur Acad Dermatol Venereol 2013; 27: 1535–1545.